Remsleep

Executive Summary

Remsleep is a private medical device and digital health company headquartered in Boca Raton, Florida, founded in 2018. The company is dedicated to developing and commercializing innovative solutions for obstructive sleep apnea, with its primary product being the DeltaWave CPAP Nasal Pillow System. This system is designed to enhance patient comfort and improve therapy compliance, addressing a critical challenge in the sleep apnea market where traditional CPAP masks often lead to poor adherence. Remsleep's mission is to engineer devices that prioritize comfort and effectiveness, potentially reducing the burden of sleep apnea on patients. As a private entity, the company does not disclose financials or valuation, and its development stage remains unspecified, though its inclusion in industry directories suggests active progress toward commercialization. Despite limited public information, Remsleep operates in a large and growing sleep apnea device market, driven by increasing diagnosis rates and demand for patient-friendly alternatives. The company's focus on compliance-friendly design positions it to capture market share if its product gains regulatory clearance and commercial traction. However, with no disclosed revenue, partnerships, or clinical data, the company's near-term outlook hinges on achieving key milestones such as FDA clearance and initial market entry. Investors should monitor regulatory filings and potential strategic alliances as indicators of progress.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for DeltaWave CPAP Nasal Pillow System65% success
• Q4 2026First Commercial Launch or Partnership Agreement50% success
• Q1 2027Publication of Clinical Data on Patient Compliance40% success